<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04777474</url>
  </required_header>
  <id_info>
    <org_study_id>23/RVO-FNOs/2020</org_study_id>
    <secondary_id>23/RVO-FNOs/2020</secondary_id>
    <nct_id>NCT04777474</nct_id>
  </id_info>
  <brief_title>Benefit of Enhanced Contact Endoscopy in Pre-histological Diagnosis of Laryngeal and Hypopharyngeal Mucosal Lesions</brief_title>
  <official_title>Determination of Diagnostic Benefit of Enhanced Contact Endoscopy (ECE) in Pre-histological Diagnosis of Laryngeal and Hypopharyngeal Mucosal Lesions</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Ostrava</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital Ostrava</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The focus of the study is to verify the role of enhanced contact endoscopy in early&#xD;
      identification of high-risk vascular patterns of precancerous and malignant mucosal changes&#xD;
      in ear-nose-throat (ENT) patients, in comparison with other standard imaging techniques.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Endoscopy methods are inseparable part in diagnostics of patients with head and neck cancer.&#xD;
      Nowadays ENT surgeons are offered a wide variety of endoscopy methods. The methods that&#xD;
      caused revolution in early diagnostics of head and neck cancer were advanced imagining&#xD;
      endoscopy methods such as NBI or IMAGE1S.&#xD;
&#xD;
      The new only recently introduced method is enhanced contact endoscopy, which uses a&#xD;
      combination of advanced imagining, such as NBI or IMAGE1S, with rigid microlaryngoscope. It&#xD;
      is believed that this technology has the potential to visualise vascular patterns of&#xD;
      precancerous and malignant mucosal changes even better than narrow-band imaging (NBI) and&#xD;
      IMAGE1S. This improvement in diagnostics helps with early identification of high-risk lesions&#xD;
      and moves us closer to the concept of pre-histological diagnostics, which helps to accelerate&#xD;
      making final diagnosis, which leads to prompt treatment.&#xD;
&#xD;
      Study protocol:&#xD;
&#xD;
        -  anamnestic questionnaire (age, sex, weight, height, smoking, alcohol, reflux disease)&#xD;
&#xD;
        -  Reflux Symptom Index (RSI) questionnaire&#xD;
&#xD;
        -  endoscopy in white light in local anaesthesia with evaluation:&#xD;
&#xD;
        -  character of the lesion (benign, Reinke edema, cyst, polyp, chronic&#xD;
           laryngitis/pharyngitis, leukoplakia, erythroplakia, malignity)&#xD;
&#xD;
        -  bleeding or ulceration on the surface of the lesion&#xD;
&#xD;
        -  endoscopy with NBI endoscope in local anesthesia with evaluation:&#xD;
&#xD;
        -  mucosa vascularization according to the ELS classification&#xD;
&#xD;
        -  size of the lesion in compare to endoscopy in white light in local anesthesia&#xD;
&#xD;
        -  occurrence of new lesions in compare to endoscopy in white light in local anesthesia&#xD;
&#xD;
        -  endoscopy in white light in general anesthesia during microlaryngoscopy&#xD;
&#xD;
        -  character of the lesion (benign, Reinkes edema, cyst, polyp, chronic&#xD;
           laryngitis/pharyngitis, leukoplakia, erythroplakia, malignity)&#xD;
&#xD;
        -  bleeding or ulceration on the surface of the lesion&#xD;
&#xD;
        -  size of the lesion in compare to endoscopy in white light in local anesthesia&#xD;
&#xD;
        -  occurence of new lesions when compared with endoscopy in white light in local anesthesia&#xD;
&#xD;
        -  endoscopy in NBI or IMAGE1S in general anesthesia during microlaryngoscopy&#xD;
&#xD;
        -  mucosa vascularization according to the ELS classification&#xD;
&#xD;
        -  size of the lesion in compare to endoscopy in white light in local anesthesia&#xD;
&#xD;
        -  occurence of new lesions in compare to endoscopy in white light in local anesthesia&#xD;
&#xD;
        -  enhanced contact endoscopy (ECE) in NBI or IMAGE1S in general anesthesia during&#xD;
           microlaryngoscopy&#xD;
&#xD;
        -  mucosa vascularization according to the ELS and Puxxedu classification&#xD;
&#xD;
        -  size of the lesion in compare to endoscopy in white light and NBI/ IMAGE1S in general&#xD;
           anesthesia&#xD;
&#xD;
        -  occurence of new lesions in compare to endoscopy in white light and NBI/&#xD;
&#xD;
      IMAGE1S in general anesthesia&#xD;
&#xD;
        -  histology examination with determination of final diagnosis&#xD;
&#xD;
        -  benign lesion&#xD;
&#xD;
        -  mild dysplasia&#xD;
&#xD;
        -  severe dysplasia&#xD;
&#xD;
        -  carcinoma in situ&#xD;
&#xD;
        -  invasive cancer&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 15, 2021</start_date>
  <completion_date type="Anticipated">December 2023</completion_date>
  <primary_completion_date type="Anticipated">December 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>The study subjects will be enrolled into one study group.</intervention_model_description>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
    <masking_description>No masking is being used in the study</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Accuracy of enhanced contact endoscopy</measure>
    <time_frame>Procedure (During the examination under general anaesthesia)</time_frame>
    <description>The accuracy of enhanced contact endoscopy will be observed (size of lesions in mm when compared with the other standard techniques)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Sensitivity of enhanced contact endoscopy</measure>
    <time_frame>Procedure (During the examination under general anaesthesia)</time_frame>
    <description>The sensitivity of enhanced contact endoscopy in making pre-histological diagnosis using final histopathology result. will be observed.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Specificity of enhanced contact endoscopy</measure>
    <time_frame>Procedure (During the examination under general anaesthesia)</time_frame>
    <description>The specificity of enhanced contact endoscopy in making pre-histological diagnosis using final histopathology result. will be observed.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Positive predictive value of enhanced contact endoscopy</measure>
    <time_frame>Procedure (During the examination under general anaesthesia)</time_frame>
    <description>The positive predictive value of enhanced contact endoscopy in making pre-histological diagnosis using final histopathology result. will be observed.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Negative predictive value of enhanced contact endoscopy</measure>
    <time_frame>Procedure (During the examination under general anaesthesia)</time_frame>
    <description>The negative predictive value of enhanced contact endoscopy in making pre-histological diagnosis using final histopathology result. will be observed.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Laryngeal Disease</condition>
  <condition>Laryngeal Lesions</condition>
  <condition>Hypopharyngeal Lesions</condition>
  <condition>Suspected Laryngeal Cancer</condition>
  <condition>Suspected Hypopharyngeal Cancer</condition>
  <condition>Proven Laryngeal Cancer</condition>
  <condition>Proven Hypopharyngeal Cancer</condition>
  <arm_group>
    <arm_group_label>Enhanced contact endoscopy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The study subjects will undergo enhanced contact endoscopy</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Enhanced contact endoscopy</intervention_name>
    <description>The study subjects will undergo enhanced contact endoscopy - studied imaging technique</description>
    <arm_group_label>Enhanced contact endoscopy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Narrow band imaging</intervention_name>
    <description>The study subjects will undergo narrow band imaging - comparator procedure</description>
    <arm_group_label>Enhanced contact endoscopy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>IMAGE1S imaging</intervention_name>
    <description>The study subjects will undergo IMAGE1S imaging - comparator procedure</description>
    <arm_group_label>Enhanced contact endoscopy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age 18 and older&#xD;
&#xD;
          -  patients scheduled for direct hypopharyngoscopy and laryngoscopy in general&#xD;
             anaesthesia&#xD;
&#xD;
          -  benign laryngeal and hypoharyngeal disease/laryngeal and hypopharyngeal lesions of&#xD;
             uncertain biologic behaviour (leukoplakia, erythroplakia, keratosis)&#xD;
&#xD;
          -  patients with suspicious macroscopical lesion found during ENT examination/patients&#xD;
             with histologically confirmed metastasis of carcinoma in neck lymph node with unknown&#xD;
             primary origin of the tumour&#xD;
&#xD;
          -  patients with recurrence of malign tumour in hypopharynx or larynx&#xD;
&#xD;
          -  patients after radiotherapy indicated for follow up examination under general&#xD;
             anaesthesia&#xD;
&#xD;
          -  patients with persistent non-specific problems (hoarseness, swallowing problems etc.)&#xD;
             indicated to direct laryngohypopharyngoscopy due to diagnostic purposes&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  age - younger than 17 years&#xD;
&#xD;
          -  refusal to join the study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Peter Kántor, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Ostrava</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jiří Hynčica</last_name>
    <phone>0042059737</phone>
    <phone_ext>2587</phone_ext>
    <email>jiri.hyncica@fno.cz</email>
  </overall_contact>
  <location>
    <facility>
      <name>University Hospital Ostrava</name>
      <address>
        <city>Ostrava</city>
        <state>Moravian-Silesian Region</state>
        <zip>70852</zip>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jiří Hynčica</last_name>
      <phone>0042059737</phone>
      <phone_ext>2587</phone_ext>
      <email>jiri.hyncica@fno.cz</email>
    </contact>
    <investigator>
      <last_name>Peter Kántor, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Lucia Staníková, MD,Ph.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Karol Zeleník, Assoc.Prof.,MD,Ph.D.,MBA</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Pavel Komínek, Prof.,MD,Ph.D.,MBA</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospital Hradec Králové</name>
      <address>
        <city>Hradec Králové</city>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anna Švejdová, MD</last_name>
      <phone>0042049583</phone>
      <phone_ext>3 221</phone_ext>
      <email>anna.svejdova@fnhk.cz</email>
    </contact>
    <investigator>
      <last_name>Anna Švejdová, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Czechia</country>
  </location_countries>
  <reference>
    <citation>Puxeddu R, Sionis S, Gerosa C, Carta F. Enhanced contact endoscopy for the detection of neoangiogenesis in tumors of the larynx and hypopharynx. Laryngoscope. 2015 Jul;125(7):1600-6. doi: 10.1002/lary.25124. Epub 2015 Jan 13.</citation>
    <PMID>25582112</PMID>
  </reference>
  <reference>
    <citation>Mehlum CS, Døssing H, Davaris N, Giers A, Grøntved ÅM, Kjaergaard T, Möller S, Godballe C, Arens C. Interrater variation of vascular classifications used in enhanced laryngeal contact endoscopy. Eur Arch Otorhinolaryngol. 2020 Sep;277(9):2485-2492. doi: 10.1007/s00405-020-06000-z. Epub 2020 Apr 30.</citation>
    <PMID>32350646</PMID>
  </reference>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>February 23, 2021</study_first_submitted>
  <study_first_submitted_qc>March 1, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 2, 2021</study_first_posted>
  <last_update_submitted>June 29, 2021</last_update_submitted>
  <last_update_submitted_qc>June 29, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 30, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>laryngeal cancer</keyword>
  <keyword>hypopharyngeal cancer</keyword>
  <keyword>laryngeal disease</keyword>
  <keyword>enhanced contact endoscopy</keyword>
  <keyword>narrow band imaging</keyword>
  <keyword>IMAGE1S method</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Laryngeal Neoplasms</mesh_term>
    <mesh_term>Hypopharyngeal Neoplasms</mesh_term>
    <mesh_term>Laryngeal Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>There is no plan to make individual participant data available to other researchers. The data may be provided upon request.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

